Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 16:16
Lakefront Biotherapeutics Price : 29.52 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 29.09 | 30.05 | 28.96 | 30.00 | 362251.0 |
| Oct 06, 2026 | 29.75 | 29.90 | 29.09 | 29.32 | 452120.0 |
| Oct 05, 2026 | 29.38 | 29.91 | 29.24 | 29.51 | 439658.0 |
| Oct 02, 2026 | 28.94 | 29.44 | 28.88 | 29.37 | 270234.0 |
| Oct 01, 2026 | 29.31 | 29.82 | 28.71 | 28.86 | 341548.0 |
| Sep 30, 2026 | 29.83 | 30.08 | 29.59 | 29.65 | 188590.0 |
| Sep 29, 2026 | 29.70 | 29.93 | 29.48 | 29.52 | 198890.0 |
| Sep 28, 2026 | 29.01 | 30.02 | 28.96 | 29.84 | 206618.0 |
| Sep 25, 2026 | 30.15 | 30.19 | 29.30 | 29.38 | 250702.0 |
| Sep 24, 2026 | 30.09 | 30.67 | 29.86 | 30.36 | 435336.0 |
| Sep 23, 2026 | 31.13 | 32.41 | 30.66 | 30.72 | 636675.0 |
| Sep 22, 2026 | 29.56 | 30.28 | 29.56 | 30.19 | 451838.0 |
| Sep 21, 2026 | 28.67 | 29.73 | 28.60 | 29.59 | 208124.0 |
| Sep 18, 2026 | 28.77 | 29.11 | 28.51 | 28.55 | 459128.0 |
| Sep 17, 2026 | 27.92 | 28.97 | 27.92 | 28.91 | 467613.0 |
| Sep 16, 2026 | 27.93 | 28.00 | 27.24 | 27.53 | 415607.0 |
| Sep 15, 2026 | 26.71 | 28.07 | 26.63 | 27.92 | 890385.0 |
| Sep 14, 2026 | 27.02 | 27.08 | 26.66 | 26.71 | 249377.0 |
| Sep 11, 2026 | 27.30 | 27.30 | 26.78 | 26.81 | 245821.0 |
| Sep 10, 2026 | 27.29 | 27.30 | 26.80 | 26.81 | 170024.0 |
| Sep 09, 2026 | 27.59 | 27.93 | 27.40 | 27.43 | 130772.0 |
| Sep 08, 2026 | 28.01 | 28.10 | 27.58 | 27.63 | 158569.0 |
| Sep 04, 2026 | 28.65 | 29.04 | 28.38 | 28.49 | 208179.0 |
| Sep 03, 2026 | 29.00 | 29.13 | 28.76 | 29.02 | 394301.0 |
| Sep 02, 2026 | 28.88 | 29.46 | 28.72 | 28.81 | 215155.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 147.04 |
| ACADIA Pharmaceuticals, Inc. | 19.57 |
| Alkermes Plc | 40.11 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Amarin Corp. Plc | 12.01 |
Price Related Metrics
| PE Ratio | 2.805 |
| PS Ratio | 1.714 |
| Price to Book Value | 0.5195 |
| Earnings Yield | 35.65% |
| Market Cap | 1.938B |
| Operating PE Ratio | 2.878 |
| Normalized PE Ratio | 2.211 |